Q4What is the histology and risk of malignant transformation in fibrous dysplasia?▸
Histology: alphabet soup appearance - trabeculae of osteoid within fibrous stroma
Malignant transformation 1% (osteosarcoma/fibrosarcoma); 5-10% in polyostotic disease (per notes)
Nocturnal pain suggests malignant transformation
Q5What are the indications and principles of surgery in fibrous dysplasia?▸
Indications: pathological fracture, enlarging lesion, recurrent fracture/deformity, high stress area (femoral neck)
Polyostotic: mainly deformity correction and fracture prevention
Monostotic: curettage; monostotic -> aim to remove tumor (curative)
Curettage, allograft (autograft transforms into fibrous tissue), stable titanium IM nail +/- osteotomy
Q6What medical treatment is used in fibrous dysplasia?▸
Bisphosphonate for symptomatic polyostotic patients: pain relief, decrease fracture, partial resolution of lesion
Denosumab - ongoing study (J Bone Miner Res 2021)
Q7Which patients and bones are affected by fibrous dysplasia?▸
Can involve any bone
More common in females
Q8What deformities can fibrous dysplasia cause?▸
Mono-ostotic vs polyostotic disease
Coxa vara with Trendelenburg gait
Blindness with skull involvement
Q9What natural history of fibrous dysplasia must patients be counselled about?▸
Progression of the existing lesion + appearance of new lesions
Old lesions will not mature - problem of remodelling: decreased cellularity, increased collagen deposition, persistent woven bone, no compressive/tensile trabeculae -> progressive deformity
Progressive deformity until maturity, but may progress again with maturity
Q10What investigations are performed in fibrous dysplasia?▸
Q25What is the classic clinical presentation of osteoid osteoma?▸
Night pain, worse after alcohol, relieved by NSAIDs
Flexion contracture of the knee
Painful scoliosis
Q26What is the double-density sign on bone scan?▸
A small focus of intense radioactivity in the nidus
Superimposed on a larger area of lower, but still increased, radioactivity
Q27How is nidus size used to distinguish osteoid osteoma from osteoblastoma?▸
CT delineates the nidus: <1.5cm = osteoid osteoma
>1.5cm = osteoblastoma (typically 3-4cm)
Q28What are the management options for osteoid osteoma?▸
Conservative NSAIDs: 50% treated with NSAID alone; sole treatment in spinal involvement without scoliosis; self-resolves in 3 years
CT-guided radiofrequency ablation: failed conservative or juxta-articular lesions with contracture; controversial in spine as close to neural elements, need 1cm safe zone in spine; 85% success
RFA complications: skin burn, stress riser at long bone; allows concomitant biopsy
Surgery (marginal excision): failed conservative when RFA not possible, painful scoliosis; CT navigation adjunct
Q29What are the differences between osteoid osteoma and osteoblastoma?▸
Nidus size: <1.5cm (osteoid osteoma) vs >1.5cm/typically 3-4cm (osteoblastoma)
Location: proximal femur > tibia > spine vs posterior elements of the spine > proximal femur
Course: self-limiting vs progressive; NSAID relief yes vs no
Surgery: +/- vs yes; osteoblastoma has more giant cells histologically
Q30What is the pathophysiology of pain in osteoid osteoma?▸
Nidus of central woven bone with osteoblastic rimming surrounded by a reactive zone
Pain due to prostaglandin E2 concentration and COX1/2 expression
Increased unmyelinated nerve endings within
Spontaneous bleeding within
Q31What is the histology of osteoid osteoma?▸
Distinct border between the osteoid nidus and reactive bone
Nidus of immature osteoid + osteoblastic rim
Increased mitotic figures with normal NC ratio
Osteoblastoma = more giant cells
Q32What investigations are performed for a suspected osteoid osteoma?▸
Blood test to rule out infection
X-ray: reactive bone with a radiolucent nidus
CT to delineate the size of the nidus
Bone scan: double-density sign
Q33Describe the CT findings in this patient.▸
Axial cut showing a lytic lesion over the facet
Expansile, with no cortical breakage and no periosteal reaction
Q53What is the histology and treatment of non-ossifying fibroma?▸
Fibroblastic spindle cells in a storiform pattern (whorls of elongated spindle cells)
Treatment: always conservative
Ddx: UBC, ABC, fibrous dysplasia, infection
Q54What are the differentials and MRI findings in CMF?▸
Ddx: NOF, ABC, chondroblastoma with breaching of the physis
MRI: T1 hypointense, T2 hyperintense
Q55What is the biopsy appearance of chondromyxoid fibroma?▸
Hypercellular fibrous matrix
Hypocellular chondroid matrix
Stellate spindle cells in a myxoid matrix
Q56What is the management and recurrence rate of CMF?▸
Intra-lesional curettage + bone graft/cement
Recurrence up to 30%
Q57Describe the X-ray findings in chondromyxoid fibroma.▸
Skeletally immature patient
Lytic lesion at the proximal tibial metaphysis
Eccentrically located with cortical expansion and destruction
Narrow zone of transition
No periosteal reaction or soft tissue swelling
Dx: CMF
Fact check
Malignant transformation in fibrous dysplasia is 1%, rising to 5-10% in polyostotic disease — Overstated for polyostotic disease — Published series report ~0.4-1% overall and up to ~4% in McCune-Albright/familial cases; 5-10% is higher than most sources — (medium confidence) — source